Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer immunotherapy targeting the telomerase reverse transcriptase.

Long Fei Huo1, Janice Ws Tang, Jun Jian Huang

  • 1Open Laboratory of Chemical Biology of the Institute of Molecular Technology, Department of Chemistry, The University of Hong Kong, Pokfulam, China.

Cellular & Molecular Immunology
|March 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings.

Frontiers in oncology·2019
Same author

A Phytochemical-Based Copolymer Derived from

Molecules (Basel, Switzerland)·2018
Same author

H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.

British journal of cancer·2018
Same author

miR-181d regulates human dendritic cell maturation through NF-κB pathway.

Cell proliferation·2017
Same author

MiR-34a modulates ErbB2 in breast cancer.

Cell biology international·2016
Same author

miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2016

Human telomerase reverse transcriptase (hTERT) is a promising cancer immunotherapy target. Vaccines targeting hTERT show potential for cancer treatment with minimal side effects on normal tissues.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Human telomerase reverse transcriptase (hTERT) is highly expressed in over 85% of tumors.
  • hTERT is typically absent in normal adult cells, making it a specific tumor-associated antigen (TAA).
  • This specificity offers a potential strategy for targeted cancer therapy.

Purpose of the Study:

  • To review fundamental advances in hTERT immunogenicity studies.
  • To examine early clinical trials of hTERT-based vaccines in cancer immunotherapy.
  • To assess the potential of hTERT as a target for cancer vaccines.

Main Methods:

  • Literature review of studies on hTERT immunogenicity.
  • Analysis of early-phase clinical trials involving hTERT vaccines.

Related Experiment Videos

  • Evaluation of hTERT peptides as vaccine components.

    • Main Results:

    • hTERT and its peptides have demonstrated immunogenic properties.
    • Early clinical trials explored the safety and efficacy of hTERT vaccines.
    • The review synthesizes decades of research on hTERT-targeted immunotherapy.

    Conclusions:

    • hTERT is a viable and ideal target for cancer immunotherapy vaccines.
    • Vaccines targeting hTERT offer a strategy for cancer-specific destruction.
    • Further development of hTERT vaccines holds promise for improved cancer treatment.